Journal
CLINICAL AND MOLECULAR HEPATOLOGY
Volume 26, Issue 3, Pages 305-308Publisher
KOREAN ASSOC STUDY LIVER
DOI: 10.3350/cmh.2020.0096
Keywords
Carcinoma; Hepatocellular; Sorafenib; Protein kinase inhibitors